The notices it replaced
Its page names no earlier notice: it is new, or it does not say.
Replaced by RFA-OD-27-003.
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,224,280 in first-year total cost, median $246,375.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IVBH-A (56)]5
- Special Emphasis Panel[ZRG1 VH-N (90)]3
- Special Emphasis Panel[ZRG1 IVBH-B (56)]2
Most frequent institutions
- UNIVERSITY OF COLORADO DENVER2
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER1
- MASSACHUSETTS GENERAL HOSPITAL1
- RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Characterizing DNA Methylation Dynamics in Trisomy 21-Associated Hematopoiesis and Leukemia1R21CA301237-01 | MA, SAIWAGENBLAST, ELVIN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $462,454 | ZRG1 |
| 2025 | CRISPR interference to identify HSA21 genes reducing neurogenesis1R21HD118402-01 | MUNSHI, NIKHIL VILASROTHERMEL, BEVERLY A | UT SOUTHWESTERN MEDICAL CENTER, TX | $451,000 | ZRG1 |
| 2025 | Developing and implementing community based participatory health research with young adults with Down syndrome1R21HD118449-01 | CHANNELL, MARIE MOORE | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $446,096 | ZRG1 |
| 2025 | Defining the association between trisomy 21 and placentation defects1R21HD118444-01 | BRUMBAUGH, JUSTIN | UNIVERSITY OF COLORADO, CO | $430,375 | ZRG1 |
| 2025 | Single cell analysis of dysregulated inducible DNA amplifications of immune response genes in Down syndrome1R21AI190900-01 | SULLIVAN, KELLY D. | UNIVERSITY OF COLORADO DENVER, CO | $234,000 | ZRG1 |
| 2024 | Imaging of Mitochondial Complex I function in Down Syndrome1R21AG086927-01 | PRICE, JULIE CROSAS, HERMINIA DIANA | MASSACHUSETTS GENERAL HOSPITAL, MA | $250,500 | ZRG1 |
| 2024 | Characterizing Language and Motor Development of Racially/Ethnically Diverse Infants and Toddlers with Down Syndrome1R21DC021818-01 | FLORES, MEGANVANEGAS, SANDRA | UNIVERSITY OF TEXAS AT AUSTIN, TX | $240,355 | ZRG1 |
| 2022 | type I interferon regulates angiogenesis in Down Syndrome1R21HL165411-01 | AL-ALAM, DENISEDANOPOULOS, SOULA ATHANASIA | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, CA | $242,250 | ZRG1 |
| 2022 | Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs1R21HL165406-01 | ZHAO, MINGTAO | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $234,000 | ZRG1 |
| 2022 | Abnormal HIF signaling in Down syndrome-related pulmonary hypertension1R21HL165364-01 | GALAMBOS, CSABA | UNIVERSITY OF COLORADO DENVER, CO | $233,250 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.